Radionuclide imaging of NENs

Neuroendocrine neoplasms (NENs) represent a heterogeneous group of tumours. CT or MRI, while being widely available, have recognised limitations for NENs. Consequently, molecular PET/CT imaging plays a fundamental role in NEN diagnosis, detection and characterisation, and has a high management impact, particularly on the selection of patients for radioligand therapy. 68Ga-labelled octreotide derivatives for somatostatin receptor (SSR) imaging...